Alle Targets beginnend mit CD
- CD101
- CD103
- CD109
- CD11
- CD11b
- CD11c
- CD11R1
- CD11R3
- CD123 (Talacotuzumab Biosimilar)
- CD130/gp130
- CD131
- CD133
- CD137
- CD138 (Indatuximab Biosimilar)
- CD14
- CD147
- CD15
- CD151
- CD158f1/2
- CD15s
- CD16
- CD16 / CD56
- CD160
- CD161
- CD163
- CD163L1
- CD164
- CD164L2
- CD165
- CD176
- CD177
- CD180
- CD19
- CD19 (FMC63 Biosimilar)
- CD19 (Inebilizumab Biosimilar)
- CD1a
- CD1b
- CD1b2
- CD1b3
- CD1c
- CD1d
- CD1d1
- CD1d2 Antigen
- CD1e
- Cd1w2
- CD1w3
- CD2
- CD2/CD19
- CD20
- CD200
- CD200 Receptor 3
- CD200R1
- CD200R1L
- CD200R4
- CD207
- CD209a Antigen
- CD209b Antigen
- CD209C
- CD209d Antigen
- CD209e Antigen
- CD21
- CD22
- CD22 (Epratuzumab Biosimilar)
- CD22 (Pinatuzumab Biosimilar)
- CD226
- CD235a/GYPA
- CD235ab
- CD235b/GYPB
- CD236/GYPC
- CD24
- CD247
- CD248
- CD25
- CD26 (Begelomab Biosimilar)
- CD27
- CD27 (Varlilumab Biosimilar)
- CD274 (Atezolizumab Biosimilar)
- CD274 (Avelumab Biosimilar)
- CD274 (Durvalumab Biosimilar)
- CD276
- CD28
- CD2AP
- CD2BP2
- CD3
- CD3 + CD19
- CD3 epsilon
- CD3/CD16
- CD300a
- CD300c
- CD300d
- CD300E
- CD300LB
- CD300LG
- Cd300lh
- CD301b/MGL2
- CD31
- CD32/CD16
- CD320
- CD33
- CD33 (Gemtuzumab Biosimilar)
- CD34
- CD34 Class I
- CD35
- CD36
- CD37
- CD37 (Naratuximab Biosimilar)
- CD38
- CD38 (Daratumumab Biosimilar)
- CD39
- CD3D
- CD3E (Muromonab Biosimilar)
- CD3EAP
- CD3G
- CD4
- CD4/CD25
- CD40
- CD40 (Iscalimab Biosimilar)
- CD40 Ligand
- CD40L (Ruplizumab Biosimilar)
- CD41, CD61
- CD42a
- CD42b
- CD43
- CD44
- CD44 Standard
- CD44v7
- CD45
- CD45 (Apamistamab Biosimilar)
- CD45.1
- CD45.2
- CD45RA
- CD45RA/B
- CD45RB
- CD45RC
- CD45RO
- CD46
- CD47
- CD47 (Lemzoparlimab Biosimilar)
- CD47 (Magrolimab Biosimilar)
- CD48
- CD4a
- CD5
- CD51
- CD52
- CD52 (Alemtuzumab Biosimilar)
- CD53
- CD55
- CD56
- CD56 (Lorvotuzumab Biosimilar)
- CD57
- CD58
- CD59
- CD59a
- CD59b
- CD5L
- CD6
- CD63
- CD66a/b/c
- CD66acd
- CD66acde
- CD68
- CD69
- CD7
- CD70
- CD70 (Vorsetuzumab Biosimilar)
- CD72
- CD72.1
- CD73
- CD73 (Uliledlimab Biosimilar)
- CD77
- CD79a
- CD79b
- CD8
- CD8 alpha
- CD8/CD56
- CD80
- CD80 (Galiximab Biosimilar)
- CD81
- CD82
- CD83
- CD84
- CD86
- CD8B
- CD8b.2
- CD9
- CD90
- CD90.2 / Thy-1.2
- CD93
- CD94
- CD96
- CD97
- CD97 beta
- CD99
- CD99L2
- CDA
- CDADC1
- CDC
- CDC10
- CDC123
- CDC13
- CDC14A
- CDC14B
- CDC14C
- CDC16
- CDC2 / CDK2
- CDC20
- CDC20B
- Cdc22
- CDC23
- Cdc25
- CDC25A
- CDC25B
- CDC25C
- CDC26
- CDC27
- CDC3
- Cdc33p
- CDC36
- CDC37
- CDC37L1
- CDC40
- CDC42
- CDC42 Small Effector 1
- CDC42BPA
- CDC42BPB
- CDC42EP1
- CDC42EP2
- CDC42EP3
- CDC42EP4
- CDC42EP5
- CDC42SE2
- CDC42SE2-C
- CDC45
- CDC45L
- CDC5L
- CDC6
- CDC7
- CDCA2
- CDCA3
- CDCA4
- CDCA5
- CDCA7
- CDCA7L
- CDCA8
- CDCP1
- CDCP2
- CdGAP
- CDH
- CDH10
- CDH15
- CDH18
- CDH19
- CDH22
- CDH23
- CDH26
- CDH6
- CDHB
- CDHR2
- CDHR3
- CDHR4
- CDHR5
- CDIP1
- CDIPT
- CDJ1
- CDK1
- CDK10
- CDK11
- CDK12
- CDK13
- CDK14
- CDK16
- CDK17
- CDK18
- CDK19
- CDK2
- CDK2AP1
- CDK2AP2
- CDK3
- CDK4
- CDK5
- CDK5R1
- CDK5R2
- CDK5RAP1
- CDK5RAP2
- CDK5RAP3
- CDK6
- CDK7
- CDK8
- CDKAL1
- CDKL1
- CDKL2
- CDKL3
- CDKL4
- CDKL5
- CDKN1B
- CDKN1C
- CDKN2A
- CDKN2A-AS1
- CDKN2AIP
- CDKN2AIPNL
- CDKN2B
- CDKN2C
- CDKN2D
- CDKN3
- cDNA Sequence AF251705
- cDNA Sequence BC027231
- cDNA Sequence BC031181
- CDNA Sequence BC051142
- CDNF
- CDO1
- CDON
- CDPF1
- CDR1
- CDR2L
- CDRT1
- CDRT15
- CDRT15L2
- CDRT15P2
- CDRT4
- CDS1
- CDS2
- CDSE1
- CDSP32
- CDT
- CDT1
- CDT2/RAMP
- CDV3 Homolog
- CDX2
- CDX4
- CDY1
- CDY1B
- CDY2A
- CDY2B
- CDYL
- CDYL2
Sie sind hier:
